ETS1 and neoplasm: In addition, an in vitro study showed that upregulating MIR193A decreased tumor cell proliferation and migration, at least partly, by directly targeting cyclin D1 (CCND1) and ETS proto-oncogene 1 (ETS1) expression (Chou et al., 2018).